BioLineRx Ltd. (BLRX)
NASDAQ: BLRX
· Real-Time Price · USD
3.06
-0.03 (-0.97%)
At close: May 15, 2025, 2:24 PM
-0.97% (1D)
| Bid | 3.01 |
| Market Cap | 11.37M |
| Revenue (ttm) | 28.94M |
| Net Income (ttm) | -9.22M |
| EPS (ttm) | -6 |
| PE Ratio (ttm) | -0.51 |
| Forward PE | -2.64 |
| Analyst | Buy |
| Ask | 3.1 |
| Volume | 11,372 |
| Avg. Volume (20D) | 32,113 |
| Open | 3.01 |
| Previous Close | 3.09 |
| Day's Range | 3.01 - 3.16 |
| 52-Week Range | 2.30 - 35.60 |
| Beta | 0.86 |
About BLRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BLRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BLRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
BioLineRx Ltd. is scheduled to release its earnings on May 27, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-16.8%
BioLineRx shares are trading lower after the compa...
Unlock content with
Pro Subscription
4 months ago
-40.82%
BioLineRx shares are trading lower after the company announced a $10 million registered direct offering.
